GAMMA Investing LLC Buys 17,618 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

GAMMA Investing LLC increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 20,727.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,703 shares of the technology company's stock after purchasing an additional 17,618 shares during the quarter. GAMMA Investing LLC owned approximately 0.09% of Simulations Plus worth $434,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its holdings in Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after purchasing an additional 427 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in Simulations Plus in the fourth quarter worth about $39,000. Tower Research Capital LLC TRC raised its position in Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after acquiring an additional 764 shares during the period. AlphaQuest LLC raised its position in Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after acquiring an additional 2,243 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new stake in Simulations Plus in the fourth quarter worth about $86,000. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on SLP shares. Wall Street Zen raised shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a research report on Tuesday, June 3rd. KeyCorp lifted their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. Craig Hallum lowered their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a research report on Friday, June 13th. Finally, JMP Securities reissued a "market perform" rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $41.25.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the transaction, the director now owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. This represents a 0.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 19.40% of the stock is currently owned by insiders.

Simulations Plus Trading Down 1.5%

Shares of NASDAQ SLP traded down $0.26 during midday trading on Monday, hitting $17.07. The company's stock had a trading volume of 359,451 shares, compared to its average volume of 245,813. The stock has a fifty day moving average price of $29.78 and a 200 day moving average price of $29.66. Simulations Plus, Inc. has a one year low of $16.85 and a one year high of $49.71. The firm has a market capitalization of $343.28 million, a price-to-earnings ratio of 48.77 and a beta of 0.97.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 9.18% and a return on equity of 7.86%. Simulations Plus's revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.20 EPS. On average, equities research analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.